Analyst Steve Scala works at COWEN and is focused on the Healthcare sector with 153 price targets and ratings documented since 2013 spanning on 11 stocks. Analyst's average stock valuation to be materialised ratio is 74.33% with an average time for price targets to be met of 620.6 days.
Most recent stock forecast was given on LLY, Eli Lilly and Company at 05-Dec-2022.
Steve Scala best performing recommendations are on LLY (ELI LILLY AND COMPANY).
The best stock recommendation documented was for LLY (ELI LILLY AND COMPANY) at 4/24/2018. The price target of $95 was fulfilled within 113 days with a profit of $21.65 (29.52%) receiving and performance score of 2.61.
Average potential price target upside
Currently, out of the existing stock ratings of Steve Scala - 7227 which are a Buy (68.08%), 3120 which are a Hold (29.39%), 269 which are a Sell (2.53%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
172
$13.75 (8.69%)
166
28 days ago
23/24 (95.83%)
$22.93 (27.45%)
344
Sell
153
$-5.25 (-3.32%)
135
1 months 19 days ago
20/20 (100%)
$19.5 (30.42%)
515
Buy
163
$4.75 (3.00%)
157
1 months 19 days ago
34/35 (97.14%)
$24.2 (28.52%)
414
Sell
153
$-5.25 (-3.32%)
92
1 months 19 days ago
6/6 (100%)
$25.57 (55.74%)
574
Hold
154
$-4.25 (-2.69%)
157
1 months 19 days ago
4/4 (100%)
$15.03 (18.69%)
198